Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1986 Oct;76(10):1245–1246. doi: 10.2105/ajph.76.10.1245

Some properties of saliva cotinine measurements in indicating exposure to tobacco smoking.

E Di Giusto, I Eckhard
PMCID: PMC1646658  PMID: 3752331

Abstract

The studies reported herein were designed to investigate some properties of saliva cotinine measurements in indicating exposure to tobacco smoke. Such measurements were found to be minimally affected by saliva flow rate or time since smoking as well as being sensitive to a low level of exposure to tobacco smoke. Results supported the view that the saliva cotinine assay is the most useful currently available method for objectively measuring exposure to tobacco smoke.

Full text

PDF
1246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barylko-Pikielna N., Pangborn R. M. Effect of cigarette smoking on urinary and salivary thiocyanates. Arch Environ Health. 1968 Nov;17(5):739–745. doi: 10.1080/00039896.1968.10665314. [DOI] [PubMed] [Google Scholar]
  2. Colletti G., Supnick J. A., Abueg F. R. Assessment of the relationship between self-reported smoking rate and Ecolyzer measurement. Addict Behav. 1982;7(2):183–188. doi: 10.1016/0306-4603(82)90043-0. [DOI] [PubMed] [Google Scholar]
  3. Densen P. M., Davidow B., Bass H. E., Jones E. W. A chemical test for smoking exposure. Arch Environ Health. 1967 Jun;14(6):865–874. doi: 10.1080/00039896.1967.10664853. [DOI] [PubMed] [Google Scholar]
  4. Dogon I. L., Amdur B. H., Bell K. Observations on the diurnal variation of some inorganic constituents of human parotid saliva in smokers and non-smokers. Arch Oral Biol. 1971 Jan;16(1):95–105. doi: 10.1016/0003-9969(71)90140-3. [DOI] [PubMed] [Google Scholar]
  5. Feyerabend C., Higenbottam T., Russell M. A. Nicotine concentrations in urine and saliva of smokers and non-smokers. Br Med J (Clin Res Ed) 1982 Apr 3;284(6321):1002–1004. doi: 10.1136/bmj.284.6321.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Feyerabend C., Russell M. A. Assay of nicotine in biological materials: sources of contamination and their elimination. J Pharm Pharmacol. 1980 Mar;32(3):178–181. doi: 10.1111/j.2042-7158.1980.tb12885.x. [DOI] [PubMed] [Google Scholar]
  7. Haley N. J., Axelrad C. M., Tilton K. A. Validation of self-reported smoking behavior: biochemical analyses of cotinine and thiocyanate. Am J Public Health. 1983 Oct;73(10):1204–1207. doi: 10.2105/ajph.73.10.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hengen N., Hengen M. Gas-liquid chromatographic determination of nicotine and cotinine in plasma. Clin Chem. 1978 Jan;24(1):50–53. [PubMed] [Google Scholar]
  9. Jarvis M., Tunstall-Pedoe H., Feyerabend C., Vesey C., Salloojee Y. Biochemical markers of smoke absorption and self reported exposure to passive smoking. J Epidemiol Community Health. 1984 Dec;38(4):335–339. doi: 10.1136/jech.38.4.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Langone J. J., Gjika H. B., Van Vunakis H. Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry. 1973 Nov 20;12(24):5025–5030. doi: 10.1021/bi00748a032. [DOI] [PubMed] [Google Scholar]
  11. Matsukura S., Sakamoto N., Takahashi K., Matsuyama H., Muranaka H. Effect of pH and urine flow on urinary nicotine excretion after smoking cigarettes. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):549–554. doi: 10.1002/cpt1979255part1549. [DOI] [PubMed] [Google Scholar]
  12. Mucklow J. C., Bending M. R., Kahn G. C., Dollery C. T. Drug concentration in saliva. Clin Pharmacol Ther. 1978 Nov;24(5):563–570. doi: 10.1002/cpt1978245563. [DOI] [PubMed] [Google Scholar]
  13. Pojer R., Whitfield J. B., Poulos V., Eckhard I. F., Richmond R., Hensley W. J. Carboxyhemoglobin, cotinine, and thiocyanate assay compared for distinguishing smokers from non-smokers. Clin Chem. 1984 Aug;30(8):1377–1380. [PubMed] [Google Scholar]
  14. Rosenberg J., Benowitz N. L., Jacob P., Wilson K. M. Disposition kinetics and effects of intravenous nicotine. Clin Pharmacol Ther. 1980 Oct;28(4):517–522. doi: 10.1038/clpt.1980.196. [DOI] [PubMed] [Google Scholar]
  15. Rylander R., Vesterlund J. Carbon monoxide criteria. With reference to effects on the heart, central nervous system and fetus. Scand J Work Environ Health. 1981;7 (Suppl 1):1–39. [PubMed] [Google Scholar]
  16. Vesey C. J., Saloojee Y., Cole P. V., Russell M. A. Blood carboxyhaemoglobin, plasma thiocyanate, and cigarette consumption: implications for epidemiological studies in smokers. Br Med J (Clin Res Ed) 1982 May 22;284(6328):1516–1518. doi: 10.1136/bmj.284.6328.1516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Vogt T. M., Selvin S., Hulley S. B. Comparison of biochemical and questionnaire estimates of tobacco exposure. Prev Med. 1979 Jan;8(1):23–33. doi: 10.1016/0091-7435(79)90026-4. [DOI] [PubMed] [Google Scholar]
  18. Wilcox R. G., Hughes J., Roland J. Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J. 1979 Oct 27;2(6197):1026–1028. doi: 10.1136/bmj.2.6197.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Williams R., Gillies P. Do we need objective measures to validate self-reported smoking? Public Health. 1984 Sep;98(5):294–298. doi: 10.1016/s0033-3506(84)80006-2. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES